Dara Capital US’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$410K Hold
354
– – 2.32% 16
2026
Q2
$425K Hold
354
– – 0.29% 53
2026
Q1
$326K Hold
354
– – 0.31% 62
2025
Q4
$380K Hold
354
– – 0.34% 64

Other funds holding LLY

Dara Capital US's LLY Position: Q3 2026 in Review

Dara Capital US held its Eli Lilly (LLY) position steady in Q3 2026 at 354 shares worth $410K. The position accounts for 2.32% of the portfolio, ranked #16.

Dara Capital US first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $425K in Q2 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Dara Capital US held 354 shares of Eli Lilly worth $410K as of Q3 2026.
  • Dara Capital US left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 2.32% of Dara Capital US's portfolio in Q3 2026, its #16 holding.
  • Dara Capital US first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Dara Capital US's Eli Lilly position peaked at $425K in Q2 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Dara Capital US's 13F filing for Q3 2026, filed 29 Oct 2026.